The prevalence of coronary artery disease in liver transplant candidates over age 50

Transplantation

Volumn 59, Issue 6, 1995, Pages 859-864

  Carey, William D ^a   Dumot, John A ^a   Pimentel, Ronnie R ^a   Barnes, David S ^a   Hobbs, Robert E ^a   Michael Henderson, J ^a   Vogt, David P ^a   Mayes, James T ^a   Westveer, Mary Kay ^a   Easley, Kirk A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTASIS; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; LIVER DISEASE; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

AGE FACTORS; AGED; ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HUMAN; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGE; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 0028900952     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199503000-00010     Document Type: Article

References (40)

1. Starzl TE, Todo S, Gordon R, et al. Liver transplantation in older patients. N Engl J Med 1987; 316: 484.
2. Kannel WB, Gordon T. The Framingham study: an epidemiology investigation of cardiovascular disease, vol 12. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health, 1968.
3. Coronary risk handbook. New York: American Heart Associa tion, 1973.
4. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. JAMA 1986; 256: 2835.
5. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease: new perspectives based on the Framingham study. Ann Intern Med 1979; 90: 85.
6. Crippin JS, Londor KD, Jorgensen R, et al. Hypercholesterol emia and athersclerosis in primary biliary cirrhosis: what is the risk? Hepatology 1991; 15: 858.
7. Ibels LS, Alfrey AC, Weil R. Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients. Am J Med 1978; 64: 634.
8. Divakar D, Bailey RR, Frampton CM, George PM, Walmsley TA, Murphy J. Hyperlipidemia in stable renal transplant recipients. Nephron 1991; 59: 423.
9. Raine AEG, Ledingham JGG. Cardiovascular complications af ter renal transplantation. In: Morris PJ, ed. Kidney transplantation, 2nd ed. London: Grune & Stratton; 1984: 469.
10. Cattran DC, Steiner G, Wilson DR, Fenton SSA. Hyperlipidemia after renal transplantation: natural history and pathophysiology. Ann Intern Med 1979; 91: 554.
11. Becker DM, Markakis M, Sension M, et al. Prevalence of hyper lipidemia in heart transplant recipients. Transplantation 1987; 44: 323.
12. Hess MJ, Hastillo A, Mohan A, et al. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia. Circulation 1983; 68(suppl II): 94.
13. Munoz SF, Deems RO, Mortiz MJ, Martin P, Jarrel BE, Maddrey WC. Hyperlipidemia and obesity after orthotopic liver transplantation. Transplant Proc 1991; 23: 1480.
14. Gardner MJ, Altman DG. Calculating confidence intervals for proportions and their differences. In: Gardner MJ, Altman DG, eds. Statistics with confidence. London: Br Med J 1989: 28.
15. Erikssen J, Thaulow E. Follow-up of patients with asymptomatic myocardial ischemia. In: Rutishauser W, Roskamm H, eds. Silent myocardial ischemia. Berlin: Springer, 1984: 156.
16. Froelicher VF, Thompson AJ, Longo MR Jr, Triebwasser JH, Lancaster MC. Value of exercise testing for screening asymptomatic men for latent coronary artery disease. Prog Cardiovasc Dis 1976; 18: 265.
17. Froelicher VF, Thompson AJ, Wolthuis R, et al. Angiographic findings in asymptomatic air crewmen with electrocardiographic abnormalities. Am J Cardiol 1977; 39: 32.
18. Proudfit WL, Shirey EK, Sones FM. Selective cine coronary arteriography; correlation with clinical findings in 1,000 patients. Circulation 1966; 33: 901.
19. Schaffner F. Serum cholesterol in primary biliary cirrhosis. Gas troenterology 1969; 56: 1111.
20. Kapelman B, Schaffner F. The natural history of PBC. Semin Liver Dis 1981; 1: 273.
21. Hoffbauer FW. Primary biliary cirrhosis; observations on the natural course of the disease in 25 women. Am J Dig Dis 1960; 5: 348.
22. Sherlock S. Primary biliary cirrhosis: chronic intrahepatic ob structive jaundice. Gastroenterology 1959; 37: 574.
23. Balasubramaniam K, Grambsch PM, Wiesner RH, Lindor KD, Dickson ER. Diminished survival of asymptomatic primary biliary cirrhosis: a prospective study. Gastroenterology 1990; 98: 1567.
24. Ahrens EH. The lipid disturbance in biliary obstruction and its relationship to the genesis of arteriosclerosis. Bull NY Acad Med 1950; 26: 151.
25. Bevans M, Batchelor WH. Cholangiotic cirrhosis with intrahe patic biliary tract obstruction and xanthomatosis. Am J Med 1950; 9: 133.
26. Miller WR, Pollard HM. Xanthomatous biliary cirrhosis. Ann Intern Med 1953; 3: 845.
27. Schwartz JN, Kong Y, Hackel DB, Bartel AG. Comparison of angiographic and postmortem findings in patients with coronary artery disease. Am J Cardiol 1975; 36: 174.
28. Flint A Jr. Experimental researches into a new excretory func tion of the liver consisting in the removal of cholesterine from the blood, and its discharging from the body in the form of stercorine. Am J Med Sci 1862; 44: 305.
29. McIntyre N, Harry DS, Pearson AJ. The hypercholesterolemia of obstructive jaundice. Gut 1975; 16: 379.
30. Felker TE, Hamilton RL, Vigne JL, Havel RJ. Properties of lipoproteins in blood plasma and liver perfusates of rats with cholestasis. Gastroenterology 1982; 83: 652.
31. Sabesen SM. Cholestatic lipoproteins: their pathogenesis and significance. Gastroenterology 1982; 83: 704.
32. Jahn CE, Schaffer EJ, Taam LA, et al. Lipoprotein abnormalities in primary biliary cirrhosis: association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology 1985; 89: 1266.
33. Nikkila K, Hockerstedt K, Miettinen T. Serum and hepatic cho-lestanol, squalene and noncholesterol sterols in man: a study on liver transplantation. Hepatology 1992; 15: 863.
34. Starzl TE, Bahnson HT, Hardesty RL, et al. Heart-liver trans plantation in a patient with familial hypercholesterolaemia. Lancet 1984; 1: 1382.
35. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984; 311: 1658.
36. Figuera D, Ardiaiz J, Martin-Judez V, et al. Combined trans plantation of heart and liver from two different donors in a patient with familial type Ila hypercholesterolemia. J Heart Transplant 1986; 5: 327.
37. Hoeg JM, Starzl TE, Brewer HB. Liver transplantation for treat ment of cardiovascular disease: comparison with medication and plasma exchange in homozygous familial hypercholesterolemia. Am J Cardiol 1987; 59: 705.
38. Valdivielso P, Escolar JL, Cuervas-Mons V, Pulpon LA, Chap-arro MAS, Gonzalez-Santos P. Lipids and lipoprotein changes after heart and liver transplantation in a patient with homozygous familial hypercholesterolemia. Ann Intern Med 1988; 108: 204.
39. Brush JE, Leon MB, Starzl TE, Gill C, Hoeg JM. Successful treatment of angina pectoris with liver transplantation and bilateral internal mammary bypass graft surgery in familial hypercholesterolemia. Am Heart J 1988; 116: 1365.
40. Foulk WT, Baggenstoss AH, Butt HR. Primary biliary cirrhosis: reevaluation by clinical and histologic study of 49 cases. Gastroenterology 1964; 47: 354.